{"meta":{"query_hash":"60af21122bd7","filters":{"venue":"Journal of Bioequivalence & Bioavailability"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/60af21122bd7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Bioequivalence+%26+Bioavailability"},"results":[{"id":"W2117943248","doi":"10.4172/jbb.1000113","title":"Comparative Bioavailability: Two Pramipexole Formulations in Healthy Volunteers after a Single Dose Administration under Fasting Conditions","year":2012,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioavailability; Pramipexole; Pharmacology; Medicine; Pharmacokinetics; Internal medicine; Parkinson's disease; Disease","score_opus":0.1465024108902202,"score_gpt":0.4379382427566109,"score_spread":0.2914358318663907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117943248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885048,0.0022045209,0.00041349904,0.006773807,0.00038928172,0.00058262574,0.000056873658,0.0000246003,0.0010499873],"genre_scores_gemma":[0.9964275,0.00010868173,0.0022533282,0.0008014441,0.0003256669,0.000022195787,0.000010140635,0.000012065795,0.000039012008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707884,0.00032573394,0.0012077224,0.00028382253,0.0005202572,0.0005836101],"domain_scores_gemma":[0.9974104,0.00073504617,0.0005865957,0.00029288896,0.00049175305,0.00048329108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020686057,0.00024978328,0.000621591,0.0001898055,0.00018036595,0.000049637034,0.0001253083,0.000116368734,0.0005906986],"category_scores_gemma":[0.0008132452,0.0002013321,0.00021803525,0.0006008359,0.0005533289,0.0012351245,0.00007196727,0.00065374456,0.000054230575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068489155,0.0068816934,0.9553256,0.0004231061,0.00022521391,0.000034282057,0.0031951577,0.00005233704,0.022201538,0.00044293897,0.0003286264,0.004040591],"study_design_scores_gemma":[0.0038745536,0.0034044588,0.97082,0.00033193975,0.00044089108,0.00032751754,0.004381894,0.00079227414,0.0064683626,0.00055279414,0.008207988,0.00039729298],"about_ca_topic_score_codex":0.00008520709,"about_ca_topic_score_gemma":0.00025076247,"teacher_disagreement_score":0.015733175,"about_ca_system_score_codex":0.00062099285,"about_ca_system_score_gemma":0.0003392559,"threshold_uncertainty_score":0.8210085},"labels":[],"label_agreement":null},{"id":"W2519144724","doi":"","title":"Biosimilars? pricing policies in Canada: A new challenge to provincial governments","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Medicine; Internal medicine","score_opus":0.024892823770357595,"score_gpt":0.2675882434322147,"score_spread":0.24269541966185712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519144724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794034,0.0017672965,0.00013123329,0.016468408,0.0008918689,0.0005045537,0.000041972216,0.000011465703,0.0007797977],"genre_scores_gemma":[0.9952904,0.00015104961,0.0019766765,0.001857345,0.00012619472,0.000005687568,7.2234195e-7,0.000013329734,0.00057862274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99736094,0.0002916774,0.0010935186,0.00035559156,0.00023412103,0.0006641715],"domain_scores_gemma":[0.99855685,0.00022150963,0.00042646023,0.00035998746,0.00021951713,0.00021569432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009820679,0.0002760289,0.0006366172,0.00016483541,0.00007412785,0.00003312883,0.0006141973,0.00022888638,0.001266835],"category_scores_gemma":[0.0008449968,0.00020412735,0.00016117327,0.00043661843,0.00020368297,0.0002478967,0.0002116221,0.00055583066,0.00009034159],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067981024,0.00097654987,0.3600122,0.00018613484,0.00025873937,0.000060141156,0.0011978002,0.00000817392,0.3935517,0.00025199566,0.088901944,0.15391482],"study_design_scores_gemma":[0.002524165,0.0021619962,0.7289162,0.00042980973,0.0001306118,0.00013812282,0.0022762008,0.000019461473,0.20177919,0.0010610335,0.059671514,0.00089167454],"about_ca_topic_score_codex":0.3787658,"about_ca_topic_score_gemma":0.32319453,"teacher_disagreement_score":0.36890402,"about_ca_system_score_codex":0.001320859,"about_ca_system_score_gemma":0.0018608968,"threshold_uncertainty_score":0.9996461},"labels":[],"label_agreement":null},{"id":"W2519942097","doi":"","title":"Targeting cancer stem cells: Challenges and opportunities","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dasatinib; Imatinib; Stem cell; Progenitor cell; Cancer research; Cancer stem cell; Medicine; Tyrosine kinase; Myeloid leukemia; CD34; Haematopoiesis; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Population; Immunology; Cancer; Leukemia; Biology; Internal medicine; Cell biology; Receptor","score_opus":0.08584506014930933,"score_gpt":0.295643831768893,"score_spread":0.20979877161958366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519942097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.924855,0.06856049,0.0000080205555,0.005380619,0.0003134154,0.0003342692,0.000011335212,0.000025402718,0.0005114429],"genre_scores_gemma":[0.92212975,0.07592209,0.000767081,0.00020868996,0.0002739874,0.000015534368,7.833833e-7,0.000019381083,0.0006626957],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99808913,0.00011235563,0.00072417915,0.00028209426,0.0004491726,0.00034307435],"domain_scores_gemma":[0.9982099,0.00013324068,0.00048881565,0.00030821926,0.00049303094,0.00036679115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007553791,0.00023186393,0.0005426594,0.00011803342,0.000067336194,0.000032851392,0.00015053473,0.00012828481,0.00076769583],"category_scores_gemma":[0.00006602544,0.00016661322,0.00013826722,0.00006627365,0.00047619911,0.00041348656,0.00008395268,0.00031378443,0.000030993928],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033133104,0.00074701017,0.039464865,0.0019904664,0.00047847803,0.00026409124,0.0031477776,0.000005018715,0.09401731,0.0001712969,0.005229657,0.8541527],"study_design_scores_gemma":[0.025483988,0.012823892,0.40027693,0.007738246,0.0033218195,0.003621611,0.06292158,0.0020356504,0.34305447,0.002443956,0.1330746,0.0032032642],"about_ca_topic_score_codex":0.00012629364,"about_ca_topic_score_gemma":0.000005333897,"teacher_disagreement_score":0.8509494,"about_ca_system_score_codex":0.0005665708,"about_ca_system_score_gemma":0.00050787104,"threshold_uncertainty_score":0.8405731},"labels":[],"label_agreement":null},{"id":"W2522289024","doi":"","title":"Regulatory consideration of the assessment of biosimilar products","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Harmonization; Scope (computer science); Interchangeability; Risk analysis (engineering); Business; Product (mathematics); Order (exchange); Bioequivalence; Medicine; Biotechnology; Pharmacology; Computer science; Finance; Pharmacokinetics","score_opus":0.023726712127593898,"score_gpt":0.2906560368767194,"score_spread":0.2669293247491255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522289024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912695,0.0017061571,0.00014636932,0.0050814734,0.0009297299,0.0003928946,0.000029631152,0.0000067946808,0.00043741692],"genre_scores_gemma":[0.99393153,0.00009823721,0.0055061025,0.0001667384,0.000039288796,0.0000024174171,7.6678316e-7,0.0000064628225,0.00024844796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974708,0.00070005405,0.0012017591,0.00022400272,0.00017654727,0.00022683927],"domain_scores_gemma":[0.9966766,0.00028082187,0.0012306538,0.0006111822,0.0011642991,0.00003643556],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021906125,0.00016630016,0.00053468323,0.000090891,0.00007982073,0.000011478696,0.00044097932,0.0002488533,0.00092401035],"category_scores_gemma":[0.001041458,0.00009405659,0.0002859154,0.00032774959,0.0016782793,0.0001887304,0.000127014,0.000390498,0.000007396566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034727105,0.00034327636,0.07160776,0.0001409044,0.00011198262,4.1573531e-7,0.000056846693,0.0000014212877,0.9189083,0.00061102957,0.0049275206,0.0032558062],"study_design_scores_gemma":[0.00035096984,0.0003820289,0.30186695,0.00009625162,0.00009798387,0.000032707605,0.00010795313,0.000008643961,0.6943923,0.00079856615,0.0017799045,0.00008568986],"about_ca_topic_score_codex":0.000022123972,"about_ca_topic_score_gemma":0.0000028105278,"teacher_disagreement_score":0.2302592,"about_ca_system_score_codex":0.000063876214,"about_ca_system_score_gemma":0.00036860062,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W2525897054","doi":"","title":"Some statistical issues on the evaluation of the similarity and interchangeability of biologics","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Interchangeability; Biosimilar; Bioequivalence; Risk analysis (engineering); Biochemical engineering; Computer science; Pharmacology; Biotechnology; Computational biology; Business; Medicine; Engineering; Pharmacokinetics; Biology","score_opus":0.10810246180928541,"score_gpt":0.357205385288697,"score_spread":0.2491029234794116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525897054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866003,0.0033438213,0.000057407797,0.0089143785,0.0004330447,0.00045646998,0.00010655663,0.0000039655047,0.00008406245],"genre_scores_gemma":[0.9987293,0.0002839325,0.00064604473,0.0002484744,0.00004074252,0.000004686484,9.2251526e-7,0.0000038145577,0.00004210131],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961249,0.0023576813,0.00085374404,0.00022272812,0.00023054314,0.00021037321],"domain_scores_gemma":[0.99658847,0.0012955796,0.0006532079,0.000503041,0.00092428277,0.00003543463],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0077824965,0.0001615414,0.00045973837,0.000050289113,0.00009085216,0.00001229167,0.0004790429,0.0002554963,0.0011577652],"category_scores_gemma":[0.005772903,0.0000704892,0.00018888526,0.00017536654,0.0031001293,0.000108458196,0.00019701988,0.00050066545,0.000007793876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078924454,0.0020152393,0.17512433,0.00036942033,0.0004958382,7.7430843e-7,0.00094363367,0.0000036018957,0.6788097,0.016138684,0.009312877,0.11599667],"study_design_scores_gemma":[0.0006692266,0.0017039112,0.568595,0.00015162892,0.00033831448,0.000020367148,0.00072599604,0.00013206234,0.36605328,0.06033556,0.0011122752,0.00016235905],"about_ca_topic_score_codex":0.00008079335,"about_ca_topic_score_gemma":0.000008947777,"teacher_disagreement_score":0.39347067,"about_ca_system_score_codex":0.00006121876,"about_ca_system_score_gemma":0.00010916821,"threshold_uncertainty_score":0.9997553},"labels":[],"label_agreement":null},{"id":"W2531190671","doi":"","title":"Free radical scavenging activity of the Malaysian Leech Saliva extract, Hirudinaria manillensis","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Leech Biology and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leech; Pharmacy; Traditional medicine; Lozenge; Medicine; Chemistry; Family medicine; Geography; Archaeology; World Wide Web","score_opus":0.019803026557157863,"score_gpt":0.26831410078046747,"score_spread":0.2485110742233096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531190671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145723,0.00030499158,0.00027768846,0.016544897,0.00022838956,0.00046802088,0.000025722307,0.000019829758,0.00067323865],"genre_scores_gemma":[0.9961642,0.00011002639,0.0030943356,0.00021131293,0.00020885996,0.000009537072,9.005204e-7,0.000012411033,0.00018841214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980285,0.00021202707,0.00073868054,0.0002733749,0.00043159604,0.00031582327],"domain_scores_gemma":[0.99735576,0.00026659717,0.0007049371,0.0010230874,0.000441407,0.00020818759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011690668,0.00020180565,0.00052929093,0.00010134854,0.00014759279,0.0000166316,0.00060222135,0.00025020321,0.000688024],"category_scores_gemma":[0.0008967051,0.00011881627,0.00043793165,0.00039296187,0.0010450863,0.0002494873,0.0001876031,0.00072467834,0.000032717686],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023381549,0.0009465319,0.21383971,0.00018672,0.00014138594,0.000011854906,0.00016010703,0.000001790199,0.7624573,0.00043597957,0.004670263,0.016914565],"study_design_scores_gemma":[0.0009852152,0.00045268965,0.73778754,0.00023070825,0.00025048835,0.00047935342,0.00019837025,0.00011501342,0.25560182,0.0017483289,0.0019834032,0.0001670688],"about_ca_topic_score_codex":0.00011005552,"about_ca_topic_score_gemma":0.0000068137983,"teacher_disagreement_score":0.52394783,"about_ca_system_score_codex":0.00016498138,"about_ca_system_score_gemma":0.00025556883,"threshold_uncertainty_score":0.753338},"labels":[],"label_agreement":null},{"id":"W2537045987","doi":"10.4172/jbb.1000250","title":"Designing, Development and Formulation of Mouth Disintegrating Telmisartan Tablet with Extended Release Profile Using Response Surface Methodology","year":2015,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Telmisartan; Pharmacology; Response surface methodology; Computer science; Biochemical engineering; Medicine; Biomedical engineering; Engineering; Machine learning; Internal medicine","score_opus":0.35084446584383233,"score_gpt":0.4503953101799497,"score_spread":0.09955084433611738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537045987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109447,0.0010149918,0.006864776,0.00015531972,0.0003465152,0.00039369107,0.000031402644,0.000020506046,0.00007830391],"genre_scores_gemma":[0.898973,0.000017122311,0.10075047,0.000059727758,0.00005727487,0.0000023453435,0.0000027587337,0.0000139462745,0.00012338092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946256,0.0030866812,0.0011866937,0.00031576335,0.00040700354,0.0003782439],"domain_scores_gemma":[0.9960113,0.0012348653,0.0012401715,0.00023295583,0.00089389004,0.00038679026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013230155,0.00025554444,0.0006275347,0.00014086325,0.00018652936,0.000027675034,0.00023357995,0.00028312736,0.000071243994],"category_scores_gemma":[0.0017760968,0.00019237859,0.00008334122,0.00031995858,0.00050660025,0.0004439584,0.00008077678,0.0005758698,0.0000045309466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03164845,0.00094693893,0.1704997,0.00052822725,0.00037791173,0.00011635497,0.018875822,0.0033406771,0.7555808,0.00012357988,0.00031266917,0.017648911],"study_design_scores_gemma":[0.0043075075,0.0019430672,0.017795607,0.00036381767,0.00040656657,0.0006634161,0.012711952,0.008604494,0.9489973,0.00030971837,0.0033286419,0.0005679033],"about_ca_topic_score_codex":0.000075109776,"about_ca_topic_score_gemma":0.000019551053,"teacher_disagreement_score":0.19341654,"about_ca_system_score_codex":0.00027168807,"about_ca_system_score_gemma":0.0010112695,"threshold_uncertainty_score":0.78449714},"labels":[],"label_agreement":null},{"id":"W4235998499","doi":"10.4172/jbb","title":"Journal of Bioequivalence & Bioavailability","year":2018,"lang":"fr","type":"paratext","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada","keywords":"Bioequivalence; Bioavailability; Pharmacology; Computational biology; Medicine; Computer science; Biology","score_opus":0.035405234836189715,"score_gpt":0.3246727591486874,"score_spread":0.28926752431249764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235998499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7115411,0.19172697,0.00334078,0.026833275,0.056119286,0.0016423953,0.0007553288,0.000089973415,0.007950862],"genre_scores_gemma":[0.6577451,0.21817987,0.027901579,0.0020403326,0.025281366,0.000016729658,0.00008727333,0.00043509688,0.06831263],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9806862,0.0021150173,0.009904711,0.0016794909,0.0031107995,0.0025038074],"domain_scores_gemma":[0.97118175,0.0016540696,0.012898449,0.0033965108,0.009018274,0.0018509764],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.015646936,0.0020787974,0.005672333,0.0021021527,0.00058889337,0.0001870409,0.00429759,0.01858216,0.027491605],"category_scores_gemma":[0.00937288,0.0015962736,0.0037047714,0.0029525678,0.016475482,0.001238413,0.00089140085,0.022290094,0.008433285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015451713,0.013674266,0.05860082,0.015853532,0.008227607,0.0026194346,0.0037394143,0.000054243952,0.11733153,0.0012186313,0.6845588,0.07867002],"study_design_scores_gemma":[0.005654934,0.014813184,0.0075957235,0.013082554,0.006035262,0.013544661,0.0016851661,0.00005231898,0.08176668,0.001086601,0.8526397,0.0020432565],"about_ca_topic_score_codex":0.000119209064,"about_ca_topic_score_gemma":0.000040466723,"teacher_disagreement_score":0.16808087,"about_ca_system_score_codex":0.0021692957,"about_ca_system_score_gemma":0.006634794,"threshold_uncertainty_score":0.9991954},"labels":[],"label_agreement":null}]}